Jos Lunenberg

Jos Lunenberg has been appointed as CEO of Enpicom, a Netherlands-based bioinformatics firm developing software to support immunotherapy development, patient stratification, and treatment monitoring. Lunenberg previously founded health tehcnology firm VitaMagna, and was co-owner and chief business officer for Genalice. He has also served as a member of the executive management team of Cerus Europe, Cryo-Save, and Organon.